06.28.18

Novaliq’s NovaTears Treatment for Evaporative Dry Eye Disease is Now Available across Australia and New Zealand

Source: Novaliq

06.27.18

Oyster Point Pharma Gets Green Light From FDA to Proceed With Clinical Development of Dry Eye Treatment

Source: Oyster Point Pharma

06.20.18

Bio-Tissue Highlights Publication of DREAM Study

Source: Bio-Tissue

06.19.18

Kala Pharmaceuticals Announces Update to KPI-121 0.25% Development Plan

Source: Kala Pharmaceuticals

06.19.18

Quantel Medical Launches LacryDiag Diagnostic Device for Dry Eye

Source: Quantel Medical

06.14.18

Bausch + Lomb Launches Soothe Xtra Protection Preservative Free Lubricant Eye Drops

Source: Bausch + Lomb

06.12.18

Shire Launches “Screen Responsibly” Initiative to Prioritize Eye Health in a Screen-Saturated World

Source: Shire

05.23.18

Wize Pharma Announces Presentation of New Data on LO2A in the Treatment of Dry Eye Syndrome in Patients with Sjögren’s Syndrome

Source: Wize Pharma

05.22.18

Tear Film Innovations Completes $8.5 Million Series B Funding

Source: Tear Film Innovations

05.03.18

ReGenTree Presents Results of a Comparison Study of RGN-259 and Approved Prescription Drugs for Dry Eye

Source: ReGenTree

View more stories